228 related articles for article (PubMed ID: 11848688)
1. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
Mesulam M; Guillozet A; Shaw P; Quinn B
Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
[TBL] [Abstract][Full Text] [Related]
2. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.
Mesulam MM; Guillozet A; Shaw P; Levey A; Duysen EG; Lockridge O
Neuroscience; 2002; 110(4):627-39. PubMed ID: 11934471
[TBL] [Abstract][Full Text] [Related]
6. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase-rich neurons in rat brain demonstrated by a sensitive histochemical method.
Tago H; Maeda T; McGeer PL; Kimura H
J Comp Neurol; 1992 Nov; 325(2):301-12. PubMed ID: 1281176
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase in the life cycle of amyloid plaques.
Guillozet AL; Smiley JF; Mash DC; Mesulam MM
Ann Neurol; 1997 Dec; 42(6):909-18. PubMed ID: 9403484
[TBL] [Abstract][Full Text] [Related]
11. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
Greig NH; Utsuki T; Ingram DK; Wang Y; Pepeu G; Scali C; Yu QS; Mamczarz J; Holloway HW; Giordano T; Chen D; Furukawa K; Sambamurti K; Brossi A; Lahiri DK
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17213-8. PubMed ID: 16275899
[TBL] [Abstract][Full Text] [Related]
12. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
[TBL] [Abstract][Full Text] [Related]
13. Histochemical mapping of acetylcholinesterase and butyrylcholinesterase in the medulla oblongata and pons of squirrel (Funambulus palmarum).
Bhatt DK; Tewari HB
J Neurosci Res; 1978; 3(5-6):419-39. PubMed ID: 739561
[TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.
Tasker A; Perry EK; Ballard CG
Expert Rev Neurother; 2005 Jan; 5(1):101-6. PubMed ID: 15853480
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase activity of human lung tumours varies according to their histological classification.
Martínez-Moreno P; Nieto-Cerón S; Torres-Lanzas J; Ruiz-Espejo F; Tovar-Zapata I; Martínez-Hernández P; Rodríguez-López JN; Vidal CJ; Cabezas-Herrera J
Carcinogenesis; 2006 Mar; 27(3):429-36. PubMed ID: 16272577
[TBL] [Abstract][Full Text] [Related]
16. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
18. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
20. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
Carson KA; Geula C; Mesulam MM
Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]